Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Allarity Therapeutics (ALLR) EPS (Basic) (2024 - 2025)

Allarity Therapeutics' EPS (Basic) history spans 2 years, with the latest figure at -$0.21 for Q4 2025.

  • For Q4 2025, EPS (Basic) fell 102.17% year-over-year to -$0.21; the TTM value through Dec 2025 reached -$0.8, up 99.88%, while the annual FY2025 figure was -$0.78, 95.02% up from the prior year.
  • EPS (Basic) reached -$0.21 in Q4 2025 per ALLR's latest filing, down from -$0.19 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $9.68 in Q4 2024 to a low of -$664.16 in Q1 2024.